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Abstract
Background: Obstructive Sleep Apnea (OSA) is associated with many cardiovascular and
psychiatric diseases. Day-time sleepiness is a common consequence of sleep apnea and correlates
with road-traffic accidents (RTA). Pakistan has a high prevalence of factors which predispose an
individual to OSA and death from RTAs are a huge burden. However there is a dearth of
prevalence studies in this regard. We aim to understand local relevance of the disease and estimate
the prevalence of individuals high-risk for OSA.
Methods: This cross-sectional survey was conducted among 450 individuals at Aga Khan
University Hospital (AKUH), which is a tertiary care teaching hospital in Pakistan. We used the BQ
as our measurement tool. Based on the responses, participants were grouped into high or low-risk
for OSA.
Results: Our study sample size was 418 with 63.2% males. Mean age of our study population was
30.4 SD +/- 12.3 years; and mean BMI was 23.2 SD +/- 5 kg/m2. Out of the total sample size 24.9%
reported snoring and there were twice as many males who snored as compared to females. Fortyfive individuals reported that they had nodded off to sleep while driving at least once in their
lifetime. On the other hand, the highest proportion of high risk individuals 47.6% was found in the
age group 60 or above. The overall prevalence of individuals who were high risk for sleep apnea
was 10%.
Conclusion: A significant proportion of the population is at high-risk for OSA. Our study shows
that despite low BMI and favorable craniofacial anatomy sleep apnea is still a locally relevant disease.
Given the local relevance of OSAS, it is important to increase awareness among general population
but more importantly among physicians of the developing countries, like Pakistan, about common
clinical features and pertinent risk factors and complications of OSAS.

Background
Sleep apnea is a breathing disorder characterized by snoring, breathing pauses and excessive sleepiness while
awake. It is a potentially life threatening condition that is

far more common than generally understood. It is associated with a number of cardiovascular, metabolic and
neuro-cognitive complications. These complications
include hypertension [1,2], coronary artery disease [3],
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congestive heart failure [4], cerebrovascular disease [5],
atrial fibrillation[6], glucose intolerance [7], impotence
[8] and type-2 diabetes [9]. It is also related it to increased
cardiovascular mortality [10] and a high prevalence of
psychiatric co-morbid conditions such as depression, anxiety, posttraumatic stress disorder, psychosis, and bipolar
disorders [11]. Also it correlates with road traffic accidents
involving drivers who fall asleep while driving [12].

either high risk or low risk for OSAS, with 86% sensitivity,
77% specificity, a positive predictive value of 0.89, and a
likelihood ratio of 3.79. There is only one study that has
so far been done in the Pakistani population to assess the
OSAS prevalence which has employed the use of the Berlin Questionnaire, but it was restricted to seminar participants only [19]. We also aim to assess age, BMI and/or
gender as indicators of risk for OSAS.

Published data from around the world provide information regarding prevalence of Obstructive Sleep Apnea Syndrome (OSAS) the in general population. However, while
comparing data from these studies, differences among
methodologies and diagnostic criteria used, should be
noted. Many studies used questionnaires to determine
sleep apnea or its risk, where as many relied on overnight
polysomnography (PSG) studies, which is the gold standard technique for sleep apnea diagnosis. The National
Sleep Foundation poll, using the Berlin questionnaire,
found that 26% of adults of a representative sample of the
US population was at high risk for OSAS [13].

Methods

The OSAS prevalence data from Asia is scarce, however, it
is reported that prevalence ranges from 2.1 to 7.5%; with
a male-to-female ratio of 2:1 [14,15]. In India the prevalence of obstructive sleep apnea syndrome has been
reported to be 7.5% [16]. Despite the high prevalence of
OSAS and associated complications, majority of the
patients remain undiagnosed. For example, in US 93% of
women and 82% of men with moderate to severe OSA are
clinically undiagnosed [17]. It is perhaps not unlikely that
in less developed world, like Pakistan, an even greater proportion of patients remain undiagnosed.
Systematic studies done on the Pakistani population
investigating the prevalence of OSAS are lacking. A study
done by Haqqee et al, showed a high prevalence of snoring (46%); frequency of snoring with apnea was reported
to be 7% and; snoring with apnea and excessive daytime
sleepiness was 3% [18]. Haqqee et al, however did not use
a structured and/or a standardized questionnaire or an
overnight PSG. Another study recently done on seminar
participants by the authors, Taj et al [19], reports that significant proportion of population is at risk for OSAS. Ironically, most physicians in Pakistan are unaware of the
clinical features and common associations of OSAS with
18% physicians treating sleep disturbances with sedatives
only [20].
The purpose of this cross-sectional study is to perform a
survey of a Pakistani population using the standardized
Berlin questionnaire [21] and estimate the prevalence of
individuals who are at high risk for OSAS. The questionnaire uses clinical symptoms such as snoring, day time
fatigue and hypertension to classify subjects as being

Study setting and population
The study was conducted at the Aga Khan University Hospital (AKUH), Karachi, Pakistan. It is a 542 beds tertiary
care hospital and one of the leading educational institutes
in the country. AKUH is the first hospital in Pakistan to be
awarded the prestigious Joint Commission International
Accreditation (JCIA) for practicing the highest internationally recognized quality standards in health care. It has
a large, broad based and busy out-patient service. The outpatient services range from pre-employment clinics and
executive check-up clinics to specialty clinics, such as
stroke, hepatic diseases, hand-trauma etc. Patients comprise of all walks of life, from general population, come to
this tertiary care hospital from different parts of the country. In accordance with the cultural norms, the patient
scheduled for an appointment with the consultant physician, is usually accompanied by at least one healthy
attendant, relative or friend.

This cross-sectional survey was conducted on individuals
who had come to the hospital as attendants or visitors of
the patients. The sample was collected via convenience
sampling from out-patient clinics and community health
center of the hospital. The study was in accordance to the
Helsinki declaration and the ethics review committee at
the Aga Khan University approved it. Patient information,
including names that could link an individual to the data
was not recorded to assure confidentiality. An informed
verbal consent was obtained from each participant and
documented before the administration of the questionnaire.
Inclusion criteria
All healthy individuals, above 18 years of age, who were
accompanying a patient or were visiting a friend or relative admitted in the hospital, were included. Study objectives were explained and verbal consent was obtained
prior to inclusion in the survey.
Exclusion criteria
Following individuals were excluded from the sample:

1. Any individual who was unable to read and/or understand Urdu, the national language.
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2. Any individual not willing to participate in the survey.
3. Any individual who had a current illness, except hypertension.
4. Any individual who had come to the hospital for medical advice (consultation with a physician), or for a surgical procedure or help from associated medical staff.
5. Any individual who was currently in regular follow-up
with any physician for an illness or was taking any prescription medication.
6. All persons associated with health care including doctors, nursing staff and medical students.
Study Sample size
The sample population was above 18 years of age. We
required a sample size of 443 subjects to fulfill the objectives of our study at a 95% confidence level. This sample
size was calculated assuming a 50% prevalence of OSAS
and 5% bound of error and then inflated by 15% to
account for non-respondents and incomplete questionnaires.

After rounding-off the required sample, we conducted the
Berlin questionnaire on a total of four hundred and fifty
individuals. Thirty-two did not answer one or more questions or terminated the interview before completion. A
total of 418 (94%) completed the interview (questionnaire) and were included in the final analysis.
Questionnaire
The instrument called the Berlin questionnaire [21], that
has been used to identify patients who are likely to have
OSAS [15], was used as the screening tool. It has been previously employed in similar primary care settings [21,22].
This instrument inquires about snoring behavior, daytime
sleepiness, obesity, and hypertension as symptoms which
help in classifying patients as being either high risk or low
risk for having sleep apnea syndrome. It has a sensitivity
of 0.86, a specificity of 0.77, a positive predictive value of
0.89, and a likelihood ratio of 3.79. It has been validated
as an authentic tool in identifying high risk patients for
Sleep Apnea syndrome in many, including US [22] and
Indian [23] populations. However it is not validated for
our Pakistani population. For our study, we translated the
questionnaire into Urdu, see additional files 1. Back-toback method was adopted for translation of the questionnaire.

The Berlin questionnaire begins with questions about age,
height, weight and sex. The questionnaire is then divided
into four categories. In the first category, there is one initial question about snoring, followed by four further

http://www.biomedcentral.com/1471-2377/8/50

questions about the intensity and frequency of snoring
and witnessed episodes of apneas. In the second category
there were two questions related to day time fatigue and
tiredness, followed by two questions about sleepiness
while driving. There was only one question in the third
category regarding high blood pressure. BMI was also calculated from the reported height and weight of the individual.
Data collection
The Berlin questionnaire was administered by a group of
4th year medical students of Aga Khan University, Karachi, Pakistan. Students were given ten hours of education
related to OSAS patho-physiology and its clinical features
and the questionnaire. The questionnaire was discussed
and students were trained to uniformly administer the
questionnaire and to adopt a standardized method of
interviewing.
Data entry and statistical analysis
Data was double entered and analyzed in Statistical Package for Social Sciences 14.0 (SPSS, Inc., Chicago, IL, USA)
Descriptive statistics including frequencies, means ±
standard deviations (SD) were calculated. Where appropriate, chi-square was used to calculate statistical significance for qualitative variables and student t-test was used
for qualitative variables. Based on the responses of the
participants to the Berlin questionnaire they were grouped
into either high or low risk for OSAS.

In category 1, a positive score for risk was defined as an
answer in the affirmative to either of the following question: snoring with intensity "louder than talking" or very
loud, snoring frequency > 3–4 times a week, snoring
enough to bother other people, or witnessed apneas during sleep > 3–4 times per week.
In category 2, a positive score was defined as a patient having a frequency of symptoms >3–4 times per week in two
or more questions about waking time sleepiness, and/or
drowsy driving.
In category 3, a positive score is given if the participant has
hypertension or has BMI greater than 27 kg/m2, the cutoff for obesity adjusted for the Asian population according to the latest guidelines [24,25].
Individuals were considered high risk for OSAS, if they
scored positive in two or more categories. Those who did
not have symptoms or scored positive in less than two categories were placed in the low risk group.

Results
Of the total 418 participants included in final analysis 264
(63.2%) were males and 154 (38.4%) were females. Of
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the 418 individuals, 42 were at high-risk for OSAS according to our instrument – Berlin Questionnaire. Hence, the
prevalence estimate of individuals at high-risk for OSAS
was 10%.
Mean age was 30.4 ± 12.3 yrs (31.4 ± 13.1 years for males
and 28.6 ± 10.7 years for females). The mean BMI was
23.2 ± 5. Table 1 shows different characteristics of the
study population and their means ± S.D. along with comparison of mean values by gender and risk-group.
We classified 223 individuals with BMI less than 23 to be
normal (53.3%); 136 individuals with BMI between 23
and 27 kg/m2 to be over weight (32.5%) and 59 individTable 1: Characteristics mean of the study population.

Characteristics

Mean ± S.D.

Age in years

30.38 +/- 12.3

Male
Female

31.42 +/- 13.1
28.59 +/- 10.7

Low risk group
High risk group

28.8 +/- 10.9
44.7 +/- 14.4

Height in meters

1.73 +/- 0.09
1.68 +/- 0.10

Low risk group
High risk group

1.68 +/- 0.10
1.70 +/- 0.11

69.7 +/- 10.9
57.8 +/- 11.8

Low risk group
High risk group

63.5 +/- 10.9
82.0 +/- 15.1

BMI in S.I units (kg/m2)

23.2 +/- 4.99

Male
Female

23.6 +/- 4.81
22.7 +/- 5.26

Low risk group
High risk group

22.6 +/- 4.38
28.5 +/- 6.82

15.2 +/- 3.23
12.7 +/- 1.17

Low risk group
High risk group

13.9 +/- 2.88
15.7 +/- 1.28

Of the 418 respondents, 104 (24.9%) reported snoring.
Figure 1 shows the distribution of 79 males (18.9.2%)
and 25 females (6%) snorers, with snoring being more
prevalent among men as compared to women. Presence
of snoring was also found to be more prevalent in individuals high-risk for OSAS (p-value < 0.0001). Of all those
who snored, including both risk groups, 49% reported
that they snored more than 3–4 times per week or more,
21.2% reported that their snoring was louder than talking
or very loud, and 42.3% admitted that their snoring bothered others. In the same subgroup, 24% reported witnessed pauses in breathing while asleep.
Hypertension was reported by 41 individuals (7.8%). Of
these 40 (97.6%) were males. Among the high-risk group
33.3% individuals had high blood pressure as compared
to 7.2% of those in the low-risk group. Hypertension was
found to be more prevalent in the high risk group for
OSAS (p-value < 0.001).

< 0.001

< 0.001

In our study population, the prevalence of over-weight
individuals (BMI ≥ 27 kg/m2) was significantly higher
among the high-risk for OSAS group (p < 0.0001). Among
the high-risk group, 5 (11.9%) had normal BMI (< 23 kg/
m2); 12 (28.6%) were over-weight (BMI ≥ 23 -< 27 kg/m2;
and 25 (59.5%) were obese (BMI ≥ 27 kg/m2). However,
it is important to note here that 8 individuals (19%),
among high risk, had BMI greater than 30 kg/m2.
According to our data, 66 individuals (15.8%) were positive for category 1; Eighty (19.1%) individuals for category 2; and 94 (22.5%) for category 3.

14.1 +/- 2.81

Male
Female

Figure 1 shows the distribution of age, BMI and other
characteristics of our study population by OSAS risk
group. Most of the participants fell in 20–29 years age
group (53.8%). It is interesting to note here that in the age
subgroup 'less than 20' years none of the respondent was
found to be high risk for OSAS. On the other hand, the
highest proportion of high risk individuals 47.6% was
found in the age group 60 or above. Our data shows that
the risk for OSAS increased with age up to 65 years of age.
Almost one-in-three participants (29%) aged 40 or more
were high-risk for OSAS.

0.484

65.3 +/- 12.6

Male
Female

Neck circumference in cm

< 0.001

1.68 +/- 0.10

Male
Female

Weight in Kilograms

P – value

uals with BMI greater than 27 to be obese (14.1%). Only
13 individuals had BMI of more than 30 of which 8 were
classified as High Risk. Individuals whose weight or
height was not recorded were excluded prior to data analysis and constitute those 32 individuals initially excluded.

< 0.001

Table 2 shows the distribution of responses, on Berlin
Questionnaire, by Risk Group.
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Figure
Distribution
1 of population age, gender, gender of snorers and BMI, according to OSAS Risk Group
Distribution of population age, gender, gender of snorers and BMI, according to OSAS Risk Group.

Tiredness and sleepiness was significantly common. Out
of our total population of 418 individuals, 99 (23.7%)
reported that they felt sleepy when they woke up in the
morning greater than 3–4 times per week. One hundred
and nine (26.1%) said that they felt tired during waking
time more than 3–4 times per week. A noteworthy proportion (10.8%) of our study population reported that
they had nodded off to sleep while driving at least once in
their lifetime.

Discussion and conclusion
We report the overall prevalence estimate of individuals
high-risk for OSAS to be 10%. One previous pilot study
done on a Pakistani population by the authors, Taj et al
[19], reported a much similar prevalence estimate of
12.4% among seminar attendees. Another study reports
only the prevalence of symptoms suggestive of OSA without correlating them with the risk for OSA [18].
Studies from Asia measuring prevalence of OSAS are
scarce. Indian studies done using the overnight PSG
reports prevalence estimate of Sleep Disordered Breathing
(SDB) (Apnea-Hypopnea Index (AHI) ≥ 5) from 13.74%
to 19.5% [16]. The study also reports OSAHS (SDB with
daytime hyper somnolence) to be 7.5% [16]. Data from

China by Ip and colleagues [15], however, report lower
prevalence of SDB (3.7%) and OSAS (2.1%). The methodology employed by these two studies, done in our neighboring Asian countries, is different from our Berlin
Questionnaire based study. However, there are considerable inherent similarities within the classification of Sleep
Apnea syndrome. We used Berlin Questionnaire which
has 86% sensitivity for an AHI ≥ 5 and also incorporates
day-time hyper-somnolence symptoms. It is, therefore,
reasonable to compare results with these regional studies.,
Thus the point prevalence of 10% reported by our study
concurs with the regional reports.
Studies done in United States and Europe that used Berlin
questionnaire reported 26% prevalence estimate of HighRisk for OSAS [13,22]. Our results show lower prevalence
(10%) than found in the West.
Possible reasons for this difference between prevalence of
SDB and or OSAS have been attributed to cephalometeric
differences [16]. These cephalometeric variations include
different mandibular lengths and the anteroposterior
dimensions of the nasopharynx-pharyngeal tubercle to
posterior nasal spine in the skulls from the Indian subcontinent, as compared to those from other populations. This
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Table 2: Distribution of responses to Berlin questionnaire by risk group. (n = 418)

Questions

Do you snore?
Yes
No
Don't Know
Snoring loudness
Loud as breathing
Loud as talking
Louder than talking
Very loud
Snoring frequency
Almost everyday
3–4 times/wk
1–2 times/wk
1–2 times/mo
Never or almost never
Does your snoring bother other people?
Yes
No
Don't Know
How often your breathing pauses have been noticed?
Almost everyday
3–4 times/wk
1–2 times/wk
1–2 times/mo
Never or almost never
Are you tired after sleeping?
Almost everyday
3–4 times/wk
1–2 times/wk
1–2 times/mo
Never or almost never
Are you tired during wake time?
Almost everyday
3–4 times/wk
1–2 times/wk
1–2 times/mo
Never or almost never
Have you ever fallen asleep while driving?
Yes
No
Do you have high blood pressure?
Yes
No
Don't know
Body Mass Index
Normal (<23 kg/m2)
Over weight (23 kg/m2 to less than 27.5 kg/m2)
Obese (≥ 27.5 kg/m2)

variation also point towards the possibility of an osteogenic etiology of OSAS [16]. Besides distinct genetic and
environmental influences, another possible explanation
perhaps is that western populations have a higher prevalence of obesity and mean BMI [25].

High-Risk
n (%)

Lower-Risk
n (%)

p-value

42 (100)
0 (0.00)
0 (0.00)

62 (16.5)
285 (75.8)
29 (7.71)

< 0.0001

16 (38.1)
8 (19.0)
9 (21.4)
9 (21.4)

47 (72.3)
14 (21.5)
2 (3.08)
2 (3.08)

< 0.0001

24 (57.1)
9 (21.4)
5 (11.9)
4 (9.5)
0 (0.00)

12 (18.8)
6 (9.40)
14 (21.9)
19 (29.7)
13 (20.3)

< 0.0001

28 (66.7)
14 (33.3)
0 (0.00)

16 (24.2)
40 (60.6)
10 (15.2)

< 0.0001

9 (21.4)
1 (2.40)
1 (2.40)
0 (0.00)
31 (73.8)

6 (9.10)
1 (1.50)
0 (0.00)
7 (10.6)
52 (78.8)

< 0.0001

15 (35.7)
4 (9.50)
5 (11.9)
2 (4.80)
16 (38.1)

45 (12.0)
35 (9.30)
86 (22.9)
76 (20.3)
133 (35.5)

< 0.0001

15 (35.7)
7 (16.7)
6 (14.3)
4 (9.50)
10 (23.8)

48 (12.9)
39 (10.5)
85 (22.8)
90 (24.2)
110 (29.6)

< 0.0001

7 (16.7)
35 (83.8)

38 (10.3)
332 (89.7)

14 (33.3)
27 (64.3)
1 (2.40)

27 (7.20)
339 (90.2)
10 (2.70)

< 0.0001

5 (11.9)
12 (28.6)
25 (59.5)

218 (58.0)
124 (33.0)
34 (9.00)

< 0.0001

We report 24.9% prevalence of snoring in our population,
which is similar to that reported in the Indian and Pakistani populations [16,19]. However, US population
reports as high as 52–54% prevalence of snoring symptom [13,21]. This difference, once again, emphasizes the
differences mentioned above.
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BMI has been reported to have a linear relationship with
OSAS risk in Asian [15,16] as well as Western populations
[13]. Using the BMI cut-off, which is more sensitive for the
Asian population [24,25] we expect a similar linear relationship between OSAS and BMI in our population as
well. The difference in the prevalence of obesity, even after
using a more locally sensitive cut-off, is perhaps related to
lower estimate of OSAS prevalence in our population.
There is significant difference of mean weight and BMI
between high and low risk group (p < 0.001).

along with this item of the questionnaire in further studies.

Age was also found to be an important risk factor for
OSAS as has also been found by previous surveys
[13,15,26]. In our sample population, almost one-inthree individuals were at high-risk among those aged 40
or more. Table 1 show mean age by risk group, there is significant difference of mean age between high and low risk
group (p < 0.001). We also report an increase in the
number of individuals at high risk for OSAS with increasing age till the age of 65 years. This relates to reported
decline in OSAS risk after 65 years of age [13]. However,
the number of respondents ≥ 65 years of age in our study
was small for any significant relationship.

Hypertension was frequently reported by our sample population and was significantly more common among individuals in the high risk group. OSAS is an independent
risk factor for hypertension and other cardiovascular diseases [27]. Given the high prevalence of these cardiovascular diseases, such as hypertension, in developing
countries like Pakistan [28], early recognition and appropriate management of OSAS is important. This questionnaire may be used in the office setting for screening. The
individuals identified as high-risk may be clinically confirmed using PSG.

We also report that the snoring was significantly more
common among men compared to women.(p-value
0.001) Men were also more likely to score positive for all
3 categories of the Berlin questionnaire. This conforms to
the findings of a study performed on American and European subjects found that men were more likely to snore,
drive while drowsy and experience breathing pauses during sleep [22]. Unlike previous studies [21,22], we did not
find any gender differences for OSAS risk. Perhaps, a 2:1
proportion of males-to-females in our study population
did not allow statistically significant gender differences for
OSAS risk. Interestingly, a study done on a western population with analysis restricted to individuals with BMI less
than 30 reported no difference in the rate of OSA risk
between the two sexes [22]. Another study noted greater
gender differences for OSAS risk in higher age groups [15].
These reports support our findings as 98% of our respondents have a BMI which is less than 30 and mean age of our
study population is low.
Excessive day-time sleepiness and morning fatigue correlate with OSAS risk and, also, excessive daytime sleepiness
is recognized as a strong indicator of OSAS [13,21]. In our
sample population, these symptoms were significantly
more prevalent among the high-risk group (p-value <
0.001). There is anecdotal evidence which suggests higher
prevalence of fatigue and sleepiness due to longer working
hours in this part of the world; hence these symptoms
may not necessarily be attributable to OSAS. It may prove
helpful to record the total sleeping hours of an individual

Almost eleven (10.8%) percent of our total study population reported that they had nodded off to sleep, at least
once while driving. Our reported rate is similar to that
reported in prior studies [13,21,22]. This is recognized as
an important public health hazard and in particular,
needs attention as it puts many drivers at a greater risk for
road traffic accidents [12].

Our study has certain limitations. The results are based
only on data from a single, private tertiary care hospital
that does not serve as representative of the whole population of the country. The study was conducted in an urban
centre where risk factors associated with OSAS are
expected to be high owing to the poor socio-demographic
profile and lifestyle. Although the hospital from where the
sample was taken is visited by people from rural areas as
well, we still believe that the study setting limits the findings from being representative of the whole country. We
also did not include patients who could not converse in
Urdu, and this further restricts the generalization of our
findings. Secondly, we used convenience sampling, and
so it is not possible to quantify the error in extrapolating
results to the entire population. Nevertheless, the use of
the structured and validated Berlin questionnaire in our
study strengthens the reliability of our results. It may be
noted that the Berlin questionnaire is not particularly validated for Pakistani population. Also, a two-to-one ratio
of male-to-female in our population probably overestimated the OSA-risk prevalence. The height and weight
were self reported and subsequent discrepancies in the
BMI had to be disregarded. We did not exclude participants with specific medical conditions, such as hypothyroidism, asthma, acromegaly, heart disease, renal disease,
pregnancy, hormonal replacement therapy etc., which
may further limit the strength of our analysis.
In conclusion, efforts are needed at the national and
regional level and, perhaps, in other developing countries
to address this problem. Considering the serious adverse
health and quality-of-life consequences of OSAS, it is
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important to completely decipher its epidemiology. Further assessment of the prevalence of OSAS by overnight
PSG along with appropriate screening tools will be meaningful. Apart from more accurate estimates, it will help
evaluate the aptness and validate the screening method
e.g. the Berlin questionnaire for the local population.
Given the local relevance of OSAS, it is important to
increase awareness among not only the general population but more importantly among the physicians of developing countries, like Pakistan, about the common clinical
features, pertinent risk factors and complications of OSAS.

Abbreviations
OSAS: Obstructive Sleep Apnea Syndrome; BMI: Body
Mass Index; PSG: Polysomnography; SDB: Sleep Disordered Breathing; AHI: Apnea-hypoapnea index; OSAHS:
Obstructive sleep apnea-hypopnea syndrome.

http://www.biomedcentral.com/1471-2377/8/50

5.
6.

7.

8.
9.
10.

11.

Competing interests
The authors declare that they have no competing interests.

12.

Authors' contributions
FT conceived and coordinated the study. FT and ZA performed the initial literature search, analyzed the data and
drafted the initial manuscript. ZA and MK were involved
in collection of data and data entry. Review of initial manuscript for major intellectual content was done by MA. All
authors read and approved the final manuscript.

Additional material

13.

14.
15.

16.

Additional file 1
Berlin Questionnaire (Urdu version). The Urdu translation of the Berlin
Questionnaire which was developed using back-to-back translation of the
English version of the Berlin questionnaire. Urdu is the national language
of Pakistan.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712377-8-50-S1.pdf]

17.
18.
19.
20.

Acknowledgements

21.

None.
22.

References
1.

2.
3.

4.

Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG: Association of
sleep-disordered breathing, sleep apnea, and hypertension in
a large community-based study. Sleep Heart Health Study.
Jama 2000, 283(14):1829-1836.
Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the
association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342(19):1378-1384.
Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J: Increased incidence of cardiovascular disease in middle-aged men with
obstructive sleep apnea: a 7-year follow-up. American journal of
respiratory and critical care medicine 2002, 166(2):159-165.
Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S, Bradley TD: Cardiovascular effects of continuous positive airway

23.

24.

25.

pressure in patients with heart failure and obstructive sleep
apnea. N Engl J Med 2003, 348(13):1233-1241.
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin
V: Obstructive sleep apnea as a risk factor for stroke and
death. N Engl J Med 2005, 353(19):2034-2041.
Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE,
Malouf JF, Ammash NM, Friedman PA, Somers VK: Association of
atrial fibrillation and obstructive sleep apnea. Circulation 2004,
110(4):364-367.
Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T: Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005,
165(4):447-452.
Goncalves MA, Guilleminault C, Ramos E, Palha A, Paiva T: Erectile
dysfunction, obstructive sleep apnea syndrome and nasal
CPAP treatment. Sleep Med 2005, 6(4):333-339.
West SD, Nicoll DJ, Stradling JR: Prevalence of obstructive sleep
apnoea in men with type 2 diabetes.
Thorax 2006,
61(11):945-950.
Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005,
365(9464):1046-1053.
Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M:
Association of psychiatric disorders and sleep apnea in a
large cohort. Sleep 2005, 28(11):1405-1411.
Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J: The association between sleep apnea and the risk of traffic accidents.
Cooperative Group Burgos-Santander. N Engl J Med 1999,
340(11):847-851.
Hiestand DM, Britz P, Goldman M, Phillips B: Prevalence of symptoms and risk of sleep apnea in the US population: Results
from the national sleep foundation sleep in America 2005
poll. Chest 2006, 130(3):780-786.
Lam B, Lam DC, Ip MS: Obstructive sleep apnoea in Asia. Int J
Tuberc Lung Dis 2007, 11(1):2-11.
Ip MS, Lam B, Tang LC, Lauder IJ, Ip TY, Lam WK: A community
study of sleep-disordered breathing in middle-aged Chinese
women in Hong Kong: prevalence and gender differences.
Chest 2004, 125(1):127-134.
Udwadia ZF, Doshi AV, Lonkar SG, Singh CI: Prevalence of sleepdisordered breathing and sleep apnea in middle-aged urban
Indian men. American journal of respiratory and critical care medicine
2004, 169(2):168-173.
Young T, Evans L, Finn L, Palta M: Estimation of the clinically
diagnosed proportion of sleep apnea syndrome in middleaged men and women. Sleep 1997, 20(9):705-706.
Haqqee R, Hussain SF, Mujib M, Ahmad HR: A hospital based preliminary report on sleep disordered breathing in Pakistani
population. J Ayub Med Coll Abbottabad 2002, 14(3):2-4.
Taj F, Aly Z, Arif O, Khealani B, Ahmed M: Risk for sleep apnea
syndrome in Pakistan: a cross-sectional survey utilizing the
Berlin questionnaire. Sleep Breath 2009, 13(1):103-6.
Hussain SF, Zahid S, Haqqee R, Khan JA: General physicians' perspective of sleep apnea from a developing country. Southeast
Asian J Trop Med Public Health 2003, 34(2):420-423.
Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP: Using the
Berlin Questionnaire to identify patients at risk for the sleep
apnea syndrome. Ann Intern Med 1999, 131(7):485-491.
Netzer NC, Hoegel JJ, Loube D, Netzer CM, Hay B, Alvarez-Sala R,
Strohl KP: Prevalence of symptoms and risk of sleep apnea in
primary care. Chest 2003, 124(4):1406-1414.
Sharma SK, Vasudev C, Sinha S, Banga A, Pandey RM, Handa KK: Validation of the modified Berlin questionnaire to identify
patients at risk for the obstructive sleep apnoea syndrome.
The Indian journal of medical research 2006, 124(3):281-290.
Jafar TH, Chaturvedi N, Pappas G: Prevalence of overweight and
obesity and their association with hypertension and diabetes
mellitus in an Indo-Asian population.
Cmaj 2006,
175(9):1071-1077.
Appropriate body-mass index for Asian populations and its
implications for policy and intervention strategies. Lancet
2004, 363(9403):157-163.

Page 8 of 9
(page number not for citation purposes)

BMC Neurology 2008, 8:50

26.
27.

28.

http://www.biomedcentral.com/1471-2377/8/50

Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A: Effects of
age on sleep apnea in men: I. Prevalence and severity. Am J
Respir Crit Care Med 1998, 157(1):144-148.
McNicholas WT, Bonsigore MR: Sleep apnoea as an independent
risk factor for cardiovascular disease: current evidence, basic
mechanisms and research priorities. Eur Respir J 2007,
29(1):156-178.
Goyal A, Yusuf S: The burden of cardiovascular disease in the
Indian subcontinent. Indian J Med Res 2006, 124(3):235-244.

Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2377/8/50/prepub

Publish with Bio Med Central and every
scientist can read your work free of charge
"BioMed Central will be the most significant development for
disseminating the results of biomedical researc h in our lifetime."
Sir Paul Nurse, Cancer Research UK

Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours — you keep the copyright

BioMedcentral

Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp

Page 9 of 9
(page number not for citation purposes)

